resTORbio, Inc. (97) | Human Resources (31)

Browse by Subcategory

Recent Contracts

Amended and Restated Senior Executive Cash Incentive Bonus Plan (Filed With SEC on March 15, 2022)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 15, 2022)
Form of Employment Agreement (Filed With SEC on March 15, 2022)
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Therapeutics, Inc. and Anil Singhal (Filed With SEC on September 16, 2020)
Amended and Restated 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on March 15, 2022)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Stewart Abbot, Ph.D (Filed With SEC on October 8, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Nick Harvey (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Lloyd Klickstein (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Francisco Galimi (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Carrie Krehlik (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Chen Schor (Filed With SEC on September 18, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Non-Immediately Exercisable) (Filed With SEC on September 16, 2020)
First Amendment to the Adicet Bio, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Restricted Stock Purchase Award Agreement (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel - 102) (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 3(i)) (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Immediately Exercisable) (Filed With SEC on September 16, 2020)
Adicet Therapeutics, Inc. 2015 Stock Incentive Plan (Filed With SEC on September 16, 2020)
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Bio, Inc. and Anil Singhal (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Restricted Stock Purchase Award Agreement (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 102) (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 3(i)) (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Non-Immediately Exercisable) (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Immediately Exercisable) (Filed With SEC on June 23, 2020)
Adicet Bio, Inc. 2015 Stock Incentive Plan (Filed With SEC on June 23, 2020)
Amendment to Stewart Abbots Employment Offer Letter, dated as of June 18, 2020, between Adicet Bio, Inc. and Stewart Abbot, Ph.D (Filed With SEC on June 23, 2020)
Employment Offer Letter, dated as of May 17, 2018, between the Adicet Bio, Inc. and Stewart E. Abbot (Filed With SEC on June 23, 2020)
Employment Offer Letter, dated as of November 1, 2017, between Adicet Bio, Inc. and Carrie A. Krehlik (Filed With SEC on June 23, 2020)
Amendment to Francesco Galimis Employment Offer Letter, dated as of April 25, 2020, between Adicet Bio, Inc. and Francesco Galimi, M.D. Ph.D (Filed With SEC on June 23, 2020)
Employment Offer Letter, dated as of September 4, 2019, between Adicet Bio, Inc. and Francesco Galimi, M.D. Ph.D (Filed With SEC on June 23, 2020)
Employment Agreement, dated as of May 8, 2019, between the Company and Lloyd Klickstein (Filed With SEC on August 14, 2019)